Greetings:Can anyone tell me if this stock has an American following? The company has at least some revenue, seems to be cheap relative to similar stage bios--but I see little institutional support and none from U.S. mutual funds. Any thoughts?Howie
There are two american brokers following the stock at the present time:Gruntal and Stephens. Their short term outlook ranges 10$ @ 14$ (US).The stock is relaively unknown in the US. However, it is relaively cheap in comparison to similar biotech companies.
Gencoca:Thank you for your response. On the face of it, this company has an interesting pipeline and appears undervalued.Thank you for your advice. I may very well take a position. Best wishes for the coming year,Howie